Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic tirofiban vs dual antiplatelet therapy in intracranial aneurysm endovascular treatment
ChiCTR2300075648Phase 4Completed
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Jun 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tirofiban, aspirin and clopidogrel in brain aneurysm (IA) (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoints: Incidence of whole-process ischemic events, Incidence of periprocedural ischemic events and 4 more. Started Jun 2019; status: completed.
02
Drugs
tirofibanaspirinclopidogrel
03
Conditions
brain aneurysm (IA)
Beyond the preview
Go deeper on ChiCTR2300075648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075648.